ALC:NYSE
Alcon AG
74,43 USD
arrow_downward
−0,12%(−0,090) 1D
20. stu, 11:25:05 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALC...
Otvori
74,16 USD
Najviša
75,04 USD
Najniža
74,10 USD
Trž. kap.
31,19 mlr.
Prosj. kol.
2,43 mil.
Količina
780,54 tis.
52-tjed. najviša
87,64 USD
52-tjed. najniža
61,84 USD
Beta
0,87
Dionice u optjecaju
480,40 mil.
Broj djelatnika
25 tis.
Otvori
74,16 USD
Najviša
75,04 USD
Najniža
74,10 USD
Trž. kap.
31,19 mlr.
Prosj. kol.
2,43 mil.
Količina
780,54 tis.
52-tjed. najviša
87,64 USD
52-tjed. najniža
61,84 USD
Beta
0,87
Dionice u optjecaju
480,40 mil.
Broj djelatnika
25 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 23 minute
Alcon stock: Pershing Square takes a $954 million stake
TradingView
·
prije 9 sati
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Yahoo Finance
·
prije 18 sati
Why Pershing Square Is Betting Big on Alcon Stock
Zacks
·
prije 2 dana
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG – informacije
Glavni izvršni direktorDavid J. Endicott
Zaposlenici25 tis.
Osnovano1945
SjedišteŽeneva, Ženeva, Švicarska
SektorHealth Care
Djelatnost-
Web-lokacijaalcon.com